View the 50 largest pharmaceutical companies in the world listings here
Abbott Laboratories
Rank: 34
2024 Revenues ($USD) : $5.19B
Abbott achieved robust financial performance in 2024 with full-year sales of $42.0B, representing 4.6% reported growth and 9.6% organic growth excluding COVID-19 testing. Q4 performance was particularly strong with 7.2% reported growth. The company has issued 2025 guidance projecting organic sales growth of 7.5-8.5% and remains well-positioned for continued growth through its diverse business segments and product pipeline.